Stock Analysis
- United States
- /
- Personal Products
- /
- NYSE:USNA
USANA Health Sciences First Quarter 2024 Earnings: EPS Beats Expectations
USANA Health Sciences (NYSE:USNA) First Quarter 2024 Results
Key Financial Results
- Revenue: US$227.8m (down 8.3% from 1Q 2023).
- Net income: US$16.5m (down 10.0% from 1Q 2023).
- Profit margin: 7.3% (down from 7.4% in 1Q 2023). The decrease in margin was driven by lower revenue.
- EPS: US$0.86 (down from US$0.95 in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
USANA Health Sciences EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 25%.
Looking ahead, revenue is forecast to grow 1.1% p.a. on average during the next 2 years, compared to a 6.8% growth forecast for the Personal Products industry in the US.
Performance of the American Personal Products industry.
The company's shares are up 1.7% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 2 warning signs for USANA Health Sciences you should be aware of, and 1 of them is concerning.
Valuation is complex, but we're helping make it simple.
Find out whether USANA Health Sciences is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:USNA
USANA Health Sciences
Develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
Undervalued with excellent balance sheet.